304 related articles for article (PubMed ID: 35183442)
1. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer: MARSH: Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction.
Blitzer GC; Rogus-Pulia NM; Mattison RJ; Varghese T; Ganz O; Chappell R; Galipeau J; McDowell KA; Meyers RO; Glazer TA; Kimple RJ
Cytotherapy; 2022 May; 24(5):534-543. PubMed ID: 35183442
[TBL] [Abstract][Full Text] [Related]
2. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia.
Blitzer GC; Glazer T; Burr A; Gustafson S; Ganz O; Meyers R; McDowell KA; Nickel KP; Mattison RJ; Weiss M; Chappell R; Rogus-Pulia NM; Galipeau J; Kimple RJ
Cytotherapy; 2023 Nov; 25(11):1139-1144. PubMed ID: 37589639
[TBL] [Abstract][Full Text] [Related]
3. Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia.
Blitzer GC; Paz C; Glassey A; Ganz OR; Giri J; Pennati A; Meyers RO; Bates AM; Nickel KP; Weiss M; Morris ZS; Mattison RJ; McDowell KA; Croxford E; Chappell RJ; Glazer TA; Rogus-Pulia NM; Galipeau J; Kimple RJ
Radiother Oncol; 2024 Mar; 192():110093. PubMed ID: 38224919
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study.
Jakobsen KK; Carlander AF; Grønhøj C; Todsen T; Melchiors J; Paaske N; Madsen AKØ; Kastrup J; Ekblond A; Haack-Sørensen M; Farhadi M; Maare C; Friborg J; Lynggard CD; von Buchwald C
Trials; 2023 Sep; 24(1):567. PubMed ID: 37658468
[TBL] [Abstract][Full Text] [Related]
5. Phase 1 clinical study of cell therapy with effective-mononuclear cells (E-MNC) for radiogenic xerostomia (first-in-human study) (FIH study on E-MNC therapy for radiogenic xerostomia).
Sumita Y; Iwamoto N; Seki M; Yoshida T; Honma R; Iwatake M; Ohba S; Takashi I; Hotokezaka Y; Harada H; Kuroshima S; Nagai K; Asahara T; Atsushi Kawakam I; Asahina I
Medicine (Baltimore); 2020 Jun; 99(26):e20788. PubMed ID: 32590759
[TBL] [Abstract][Full Text] [Related]
6. Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial.
Strojan P; Plavc G; Kokalj M; Mitrovic G; Blatnik O; Lezaic L; Socan A; Bavec A; Tesic N; Hartman K; Svajger U
Radiol Oncol; 2023 Dec; 57(4):538-549. PubMed ID: 38038413
[TBL] [Abstract][Full Text] [Related]
7. Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II).
Lynggaard CD; Grønhøj C; Christensen R; Fischer-Nielsen A; Melchiors J; Specht L; Andersen E; Mortensen J; Oturai P; Barfod GH; Haastrup EK; Møller-Hansen M; Haack-Sørensen M; Ekblond A; Kastrup J; Jensen SB; von Buchwald C
Stem Cells Transl Med; 2022 May; 11(5):478-489. PubMed ID: 35435231
[TBL] [Abstract][Full Text] [Related]
8. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.
Grønhøj C; Jensen DH; Glovinski PV; Jensen SB; Bardow A; Oliveri RS; Specht L; Thomsen C; Darkner S; Kiss K; Fischer-Nielsen A; von Buchwald C
Trials; 2017 Mar; 18(1):108. PubMed ID: 28270226
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled Trial.
Jakobsen KK; Carlander AF; Todsen T; Melchiors J; Paaske N; Østergaard Madsen AK; Kloch Bendtsen S; Mordhorst C; Stampe H; Kastrup J; Ekblond A; Haack-Sørensen M; Farhadi M; Maare C; Friborg J; Lynggaard CD; Werner Hauge A; Christensen R; Grønhøj C; von Buchwald C
Clin Cancer Res; 2024 May; 30(10):2078-2084. PubMed ID: 38441659
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal/stem cell therapy for radiation-induced salivary gland hypofunction in animal models: a protocol for a systematic review and meta-analysis.
Jansson PM; Lynggaard CD; Carlander AF; Jensen SB; Follin B; Hoeeg C; Kousholt BS; Larsen RT; Grønhøj C; Jakobsen KK; Rimborg S; Fischer-Nielsen A; Menon JML; von Buchwald C
Syst Rev; 2022 Apr; 11(1):72. PubMed ID: 35436971
[TBL] [Abstract][Full Text] [Related]
11. The role of stem cells in the prevention and treatment of radiation-induced xerostomia in patients with head and neck cancer.
Nevens D; Nuyts S
Cancer Med; 2016 Jun; 5(6):1147-53. PubMed ID: 26880659
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stromal/Stem Cell Therapy Improves Salivary Flow Rate in Radiation-Induced Salivary Gland Hypofunction in Preclinical in vivo Models: A Systematic Review and Meta-Analysis.
Carlander AF; Gundestrup AK; Jansson PM; Follin B; Hoeeg C; Kousholt BS; Larsen RT; Jakobsen KK; Rimborg S; Fischer-Nielsen A; Grønhøj C; Buchwald CV; Lynggaard CD
Stem Cell Rev Rep; 2024 May; 20(4):1078-1092. PubMed ID: 38430363
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX).
Grønhøj C; Jensen DH; Vester-Glowinski P; Jensen SB; Bardow A; Oliveri RS; Fog LM; Specht L; Thomsen C; Darkner S; Jensen M; Müller V; Kiss K; Agander T; Andersen E; Fischer-Nielsen A; von Buchwald C
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):581-592. PubMed ID: 29678523
[TBL] [Abstract][Full Text] [Related]
14. Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial.
Lynggaard CD; Grønhøj C; Jensen SB; Christensen R; Specht L; Andersen E; Andersen TT; Ciochon UM; Rathje GS; Hansen AE; Stampe H; Fischer-Nielsen A; von Buchwald C
Clin Cancer Res; 2022 Jul; 28(13):2890-2897. PubMed ID: 35486613
[TBL] [Abstract][Full Text] [Related]
15. Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.
Jensen SB; Vissink A; Limesand KH; Reyland ME
J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425600
[TBL] [Abstract][Full Text] [Related]
16. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
Vissink A; Mitchell JB; Baum BJ; Limesand KH; Jensen SB; Fox PC; Elting LS; Langendijk JA; Coppes RP; Reyland ME
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):983-91. PubMed ID: 20970030
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.
Riley P; Glenny AM; Hua F; Worthington HV
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012744. PubMed ID: 28759701
[TBL] [Abstract][Full Text] [Related]
18. Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.
Mercadante V; Jensen SB; Smith DK; Bohlke K; Bauman J; Brennan MT; Coppes RP; Jessen N; Malhotra NK; Murphy B; Rosenthal DI; Vissink A; Wu J; Saunders DP; Peterson DE
J Clin Oncol; 2021 Sep; 39(25):2825-2843. PubMed ID: 34283635
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of mesenchymal stem cell therapy in rodent models of radiation-induced xerostomia and oral mucositis: a systematic review.
Guan Z; Zhang J; Jiang N; Tian M; Wang H; Liang B
Stem Cell Res Ther; 2023 Apr; 14(1):82. PubMed ID: 37046350
[TBL] [Abstract][Full Text] [Related]
20. Effect of True and Sham Acupuncture on Radiation-Induced Xerostomia Among Patients With Head and Neck Cancer: A Randomized Clinical Trial.
Garcia MK; Meng Z; Rosenthal DI; Shen Y; Chambers M; Yang P; Wei Q; Hu C; Wu C; Bei W; Prinsloo S; Chiang J; Lopez G; Cohen L
JAMA Netw Open; 2019 Dec; 2(12):e1916910. PubMed ID: 31808921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]